ZVRA · ISSUER CIK 1434647
ZEVRA THERAPEUTICS, INC.
Between Aug 1, 2026 and Oct 29, 2026, 3 ZEVRA THERAPEUTICS, INC. insiders reported $0.00 of open-market purchases and $838K of sales on SEC Form 4.
↗3 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 2 of 3 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$838KInsider selling
−$838KNet open-market
Oct 13, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 13, 202616:24 | Oct 12, 2026 | ZVRA | President and CEO, Director | S · Sell10b5-1 | $11.25 | −20,000 | 417,225 | -5% | −$225K | ||
| Oct 13, 202616:24 | Oct 10, 2026 | ZVRA | President and CEO, Director | M · Exercise10b5-1 | — | +50,000 | 437,225 | +13% | — | ||
| Aug 17, 202616:32 | Aug 14, 2026 | ZVRA | Chief Legal & Compliance | S · Sell10b5-1 | $11.13 | −42,666 | 37,569 | -53% | −$475K | ||
| Aug 12, 202616:16 | Aug 10, 2026 | ZVRA | Director | S · Sell | $11.25 | −12,300 | 1,800 | -87% | −$138K | ||
| Aug 12, 202616:16 | Aug 10, 2026 | ZVRA | Director | M · Exercise | $4.97 | +12,300 | 14,100 | +683% | $61K |